BMAL1 and neoplasm: Consistent with tumor suppression, pharmacological inhibition of TGF‐βR1 abrogated Bmal1‐deletion–triggered tumor fibrosis that showed reduced positive structures of FAP, α‐SMA, DESMIN, PDGFRα, and PDGFRβ (Figure 4C–E).